'Tis the Season for a Flu Test
Executive Summary
With the introduction of two new drugs for fighting the flu, the diagnostic tests for influenza become all the more important. Several niche players are hoping that physicians will use the tests to determine which patients have the flu in order to determine how to treat them. But for drug companies eager for as many patients as possible to use their therapies, the tests are a mixed blessing. They might help drug companies score points with payers, eager to curb the costs of treating an unpleasant but not usually serious disease, but they also help to limit the use of the drug to only those people who have the flu.
You may also be interested in...
Thermo Fisher Scientific, Hillrom To Acquire Diagnostics Companies To Bolster Portfolios
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Cosmetic And Personal Care Trademark Review 19 January, 2021
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
CMS Extends National Medicare Coverage For Transcatheter Mitral Valve Repair
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.
Need a specific report? 1000+ reports available
Buy Reports